Global Autologous Platelet Rich Plasma (PRP) Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Autologous Platelet Rich Plasma (PRP) Market Insights, Forecast to 2034
Platelet-rich plasma (PRP) therapy speeds healing of injured tendons, ligaments, muscles and joints by injecting a concentration of the patient's own platelets.
Global Autologous Platelet Rich Plasma (PRP) market is expected to reach to US$ 6050 million in 2023, with a positive growth of %, compared with US$ 5482 million in 2022. Backed with the increasing demand from downstream industries, Autologous Platelet Rich Plasma (PRP) industry is evaluated to reach US$ 13280 million in 2033. The CAGR will be 14.0% during 2023 to 2033.
Globally, Autologous Platelet Rich Plasma (PRP) key manufacturers include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, Arthrex, Regen Lab, Exactech, Weigao and Emcyte Corporation, etc. Harvest Technologies, DePuy Synthes, Stryker are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Autologous Platelet Rich Plasma (PRP) were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the sales share will be % in 2033. Moreover, China, plays a key role in the whole Autologous Platelet Rich Plasma (PRP) market and estimated to attract more attentions from industry insiders and investors.
Autologous Platelet Rich Plasma (PRP) can be divided into P-PRP, L-PRP and PRF,, etc. P-PRP is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2033.
Autologous Platelet Rich Plasma (PRP) is widely used in various fields, such as Orthopedic Surgery, Plastic Surgery, General Surgery and Others, etc. Orthopedic Surgery provides greatest supports to the Autologous Platelet Rich Plasma (PRP) industry development. In 2022, global % sales of Autologous Platelet Rich Plasma (PRP) went into Orthopedic Surgery filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Autologous Platelet Rich Plasma (PRP) market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Autologous Platelet Rich Plasma (PRP) market with multiple angles. Items like regional sales, revenue from 2018 to 2033 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Regen Lab
Exactech
Weigao
Emcyte Corporation
REV-MED
Segment by Type
P-PRP
L-PRP
PRF
Orthopedic Surgery
Plastic Surgery
General Surgery
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2033
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Autologous Platelet Rich Plasma (PRP) plant distribution, commercial date of Autologous Platelet Rich Plasma (PRP), product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Autologous Platelet Rich Plasma (PRP) introduction, etc. Autologous Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Autologous Platelet Rich Plasma (PRP)
Chapter 15Methodology and Data Sources adopted by MRAResearch
Global Autologous Platelet Rich Plasma (PRP) market is expected to reach to US$ 6050 million in 2023, with a positive growth of %, compared with US$ 5482 million in 2022. Backed with the increasing demand from downstream industries, Autologous Platelet Rich Plasma (PRP) industry is evaluated to reach US$ 13280 million in 2033. The CAGR will be 14.0% during 2023 to 2033.
Globally, Autologous Platelet Rich Plasma (PRP) key manufacturers include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, Arthrex, Regen Lab, Exactech, Weigao and Emcyte Corporation, etc. Harvest Technologies, DePuy Synthes, Stryker are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Autologous Platelet Rich Plasma (PRP) were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the sales share will be % in 2033. Moreover, China, plays a key role in the whole Autologous Platelet Rich Plasma (PRP) market and estimated to attract more attentions from industry insiders and investors.
Autologous Platelet Rich Plasma (PRP) can be divided into P-PRP, L-PRP and PRF,, etc. P-PRP is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2033.
Autologous Platelet Rich Plasma (PRP) is widely used in various fields, such as Orthopedic Surgery, Plastic Surgery, General Surgery and Others, etc. Orthopedic Surgery provides greatest supports to the Autologous Platelet Rich Plasma (PRP) industry development. In 2022, global % sales of Autologous Platelet Rich Plasma (PRP) went into Orthopedic Surgery filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Autologous Platelet Rich Plasma (PRP) market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Autologous Platelet Rich Plasma (PRP) market with multiple angles. Items like regional sales, revenue from 2018 to 2033 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Regen Lab
Exactech
Weigao
Emcyte Corporation
REV-MED
Segment by Type
P-PRP
L-PRP
PRF
Segment by Application
Orthopedic Surgery
Plastic Surgery
General Surgery
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2033
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Autologous Platelet Rich Plasma (PRP) plant distribution, commercial date of Autologous Platelet Rich Plasma (PRP), product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Autologous Platelet Rich Plasma (PRP) introduction, etc. Autologous Platelet Rich Plasma (PRP) Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Autologous Platelet Rich Plasma (PRP)
Chapter 15Methodology and Data Sources adopted by MRAResearch
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices